share_log

テルモ、29年連続でグッドデザイン賞を受賞

Terumo has won the Good Design Award for 29 consecutive years.

TERUMO ·  Oct 15 23:00
largeTop

October 16, 2024

Terumo Corporation (Headquarters: Shibuya-ku, Tokyo, President: Mitsuru Samejima) is pleased to announce that two products, the rigid hysteroscope "OperaScope" and the cell proliferation system "Quantum Flex", have won the 2024 Good Design Award organized by the Japan Institute of Design Promotion.

The Good Design Award evaluates and awards designs that lead to problem solving and the discovery of new themes, regardless of tangible or intangible products, architecture, software, systems, and services. Terumo first won the award in 1989 with the artificial lung "Capiox E CX-E30" and has been winning consecutively for 29 years since 1996.

Terumo will continue to pursue contributions to the evolution of healthcare and the improvement of patients' quality of life, delivering valuable products and services that support people's health and lives.

Award-winning products and evaluation comments from the judges

* Evaluation comments from the judges are quoted from the Good Design Award website.

Rigid hysteroscope "OperaScope"

The fully disposable OperaScope package is a groundbreaking design solution that enables hysteroscopic surgery in various outpatient clinics. It opens up the possibility of performing minor lesion removal such as polyps not only in large hospitals with operating rooms but also in clinics patients visit regularly, reducing the treatment burden for many women. With all the necessary equipment such as endoscope light source, video system, and monitor included in the package, and the sterilization process eliminated, it lowers the threshold for implementation and has the potential to expand to many institutions, contributing to addressing the quantity and quality of gynecological care in Japan.

large
OperaScope

Cell proliferation system "Quantum Flex"

This product is a cell proliferation system designed for developers of cell therapy with huge potential. Unlike traditional cell culture processes, this product automates most processes and features a functionally closed platform, earning high praise. For example, it is expected to be used in research for establishing an automated cultivation process for treating with iPS cells, with further implementation anticipated. I would like to express deep respect to everyone involved in the design of this product.

large
Quantum Flex

Overview of Terumo Corporation

Terumo is a medical device manufacturer with a 100-year history, with the philosophy of 'contributing to society through medical care.' It has its headquarters in Japan and is active in more than 160 countries and regions around the world, with more than 30,000 associates working every day to deliver innovative solutions.

Starting with the production of domestically made thermometers, Terumo has continued to support the foundation of medical care. Currently, it provides a wide range of products and services related to catheter treatment, cardiovascular surgery, drug administration, diabetes management, peritoneal dialysis, transfusion and cell therapy.

Terumo aims to be a valuable company for society, including patients and healthcare professionals.

A press release is intended to provide fair and appropriate information to stakeholders about our company's information. Product information (including under development) in the text is not intended for customer solicitation or medical advice.
In addition, descriptions of the future, including expected business performance, are based on information currently available to us and certain assumptions that we consider to be reasonable, and are not intended to promise their realization on our part. Please note that various factors may cause actual business performance to fluctuate. Important factors that could affect actual performance include changes in economic conditions surrounding Terumo's business areas, fluctuations in exchange rates, and competitive conditions.

News Release Top

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment